logo
welcome
TipRanks

TipRanks

These 2 “Strong Buy” Penny Stocks Are Set to Triple (or more), Say Analysts

TipRanks
Summary
Nutrition label

77% Informative

The penny stocks offer a unique blend of risk and reward, with the potential to double or triple initial investments.

We used TipRanks database to uncover two compelling penny stocks that have earned Strong Buy ratings from the analyst community.

These tickers are set to triple or more in the coming year .

SAB Biotherapeutics has a focus on the treatment and prevention of immune and autoimmune diseases.

The company's leading drug candidate, SAB-142, is a potential blockbuster if it pans out.

Craig-Hallum analyst Albert Lowe rates SABS a Buy and set a price target of $ 11 , which implies a potential upside of 237% ..